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Background
Systemic sclerosis (SSc) is a connective tissue disorder
characterized by excessive fibrosis of the skin and inter-
nal organs, including the heart. Traditional late gadoli-
nium enhancement (LGE) by cardiovascular magnetic
resonance (CMR) imaging is dependent on differential
(i.e., focal) fibrosis within the myocardium. However,
diffuse interstitial myocardial fibrosis (DF) affecting the
entire myocardium may be missed because no normal
reference region exists. T1 mapping has been utilized
in a variety of techniques to assess diffuse fibrosis: 1)
pre-contrast T1 measurement (PreT1), 2) post-contrast
T1 measurement (PostT1), 3) partition coefficient (PC),
and 4) volume of distribution (VD). We sought to eval-
uate the accuracy of LGE and various T1 mapping
techniques for the assessment of myocardial fibrosis in
patients with SSc.
Methods
CMR was performed in 13 SSc patients (5 diffuse and 8
limited cutaneous) and 13 age-matched controls. Cine,
pre- and post-contrast T1 mapping, and late gadolinium
enhanced (LGE) imaging was performed. Calculation of
PC and VD were: PC = ΔR1myocardium/ΔR1bloodpool.
VD = [ΔR1myocardium/ΔR1bloodpool × p × (1 - hemato-
crit)] - Vp, where R1 = 1/ T1, ΔR1 is post-contrast - pre-
contrast R1, p is myocardial specific density (1.05), and Vp
is myocardial plasma volume fraction (0.045). The modi-
fied Rodnan skin score (mRSS), a measure of SSc disease
activity, was quantified in all SSc patients by clinicians
blinded to all CMR data.
Results
There was no visible LGE in 10/13 SSc and 13/13 controls.
VD was significantly higher in SSc than controls (27.4 ±
4.6% vs. 20.6 ± 3.3%, p = 0.0003), even when patients with
visible LGE were excluded (26.9 ±4.0% vs. 20.6 ± 3.3%,
p = 0.001). PreT1, PC, and VD all correlated significantly
with log mRSS in SSc patients, the correlation for PostT1
was not significant (Figure 1 and Table 1). Comparison of
correlation coefficients demonstrates VD > PreT1 > PD >
PostT1.
Conclusions
This is the first study to compare various T1 mapping
techniques for the assessment of diffuse interstitial myo-
cardial fibrosis in patients with SSc. PreT1 provides a
surprisingly good assessment of DF in SSc, and may be
useful in patients with impaired renal function. Calculation
of VD - which requires measurement of hematocrit,
PreT1, and PostT1 - is more time consuming but provides
the most accurate assessment of DF in SSc. Calculation of
PC and PostT1 - which allow one to eliminate hematocrit
or hematocrit and PreT1, respectively - provide simpler
but less accurate measures of DF in SSc.
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Figure 1 Scatter plots for CMR measures of diffuse fibrosis versus scleroderma severity by mRSS
Table 1 Correlation with Systemic Sclerosis Severity by
mRSS
CMR Parameter Equation R value p-value
Pre-Contrast T1 y = 0.0032x - 2.2 0.61 0.028
Post-Contrast T1 y = 0.0025x - 0.045 0.38 0.20
Partition Coefficient y = 2.7x - 0.28 0.57 0.041
Volume of Distribution y = 0.052x - 0.39 0.76 0.0025
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